NICE has recommended the use of Boston Scientific’s CRT-D for the treatment of heart failure patients.
IBM Watson Health will integrate MedyMatch's decision support-tool into its imaging offerings.
AliveCor is launching a new platform to help physicians manage reports from its smartphone ECG recorder.
RenalGuard Solutions raised $14.5 million in a Series A round. The funds will support the pivotal trial of a device that protects the kidneys.
Medtronic is recalling its SynchroMed implantable infusion pumps due to a software glitch.
Cardiva raised $30 million in equity, which will bankroll the expansion of its bioabsorbable vascular closure system and advance technologies in its pipeline.
Sanofi has teamed up with Voluntis to run pilot programs featuring a prescription-only smartphone app for managing Type 2 diabetes.
SUNY Downstate researchers have developed a wearable device that allows ALS patients who are completely “locked in” to communicate.
The FDA cleared a new version of Medtronic's Reveal Linq, which now includes algorithms that ramp up the implant’s accuracy in reporting abnormal…
Myriad Genetics is rolling out a test for early-stage breast cancer that gauges the risk of recurrence after surgery and identifies patients who can skip chemo.